 |
|
|
|
Disclosing Negative Results
Practical & proactive strategies to effectively negotiate this tough process
August 18, 2009
1:30 p.m. ET
90 minutes
Part 2 of a 4-part series: Evolving Issues in Publication Planning: Smart Strategies for Success
When disclosing negative results, publication planners must not only ensure they’re meeting all regulatory requirements – they also have to prepare their team and the company for any repercussions. This 90-minute webinar addresses the hard and soft issues associated with negative results disclosure, and provides attendees with the tools they need to successfully navigate this difficult landscape. Key issues include:
- Reviewing the checklist: The obligations publication planners must meet to comply with FDAAA and other publication guidelines
- The regulatory bodies: Ensuring you comply with FDA requirements for results disclosure
- The data is out there now: Preparing your team and the company for any repercussions
- What role does/should publications take in the context of the larger corporation communications?
Presenters:
Colleen Gilbert, VP, Clinical Affairs, CommGeniX, LLC
Elizabeth Crane, Senior Manager, Medical Publications, Astellas Pharma Global Development, Inc
Jane Moore, Principal Publications Specialist, Medtronic
Register Today!
Individual Registration - $395
Any subsequent registrations will receive a 15% discount.
*Group Registration Options - $1,995
Access for 45 or fewer attendees from the same company. For group registrations of 45 or more, please contact Kathie Eberhard at 704-341-2439 or keberhard@frallc.com.
*Please note when registering delegates under Group Registrations you must submit an advance list of attendees from your organization including email address and name.
|
|
|
|